In vitro models of aortic valve calcification: Solidifying a system

Cardiovascular Pathology

Volumn 24, Issue 1, 2015, Pages 1-10

  Bowler, Meghan A ^a   Merryman, W David ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

Calcific aortic valve disease; In vitro; Model; Quantification methods

Indexed keywords

CALCIUM;

AORTA VALVE DISEASE; ARTERY CALCIFICATION; CLINICAL EVALUATION; ENVIRONMENTAL FACTOR; HEART VALVE REPLACEMENT; HUMAN; HYPOTHESIS; IN VITRO STUDY; LEYDIG CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; THORAX SURGERY; ANIMAL; AORTA VALVE; AORTA VALVE STENOSIS; BIOLOGICAL MODEL; CALCINOSIS; PATHOLOGY;

ANIMALS; AORTIC VALVE; AORTIC VALVE STENOSIS; CALCINOSIS; HUMANS; IN VITRO TECHNIQUES; MODELS, BIOLOGICAL;

EID: 84920719155     PISSN: 10548807     EISSN: 18791336     Source Type: Journal    
DOI: 10.1016/j.carpath.2014.08.003     Document Type: Review

References (140)

1. U.S. Aortic Stenosis Disease Prevalence & Treatment Statistics. Accessed at http://umm.edu/programs/services/heart-center-programs/cardiothoracic-surgery/valve-surgery/facts; 2013.
2. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB, et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012;125:e2-220.
3. Lindroos M, Kupari M, Heikkila J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-5.
4. Aging Ao. In: Services DoHH, editor. Projected Future Growth of the Older Population; 2000.
5. Hermans H, Herijgers P, Holvoet P, Verbeken E, Meuris B, Flameng W, et al. Statins for calcific aortic valve stenosis: into oblivion after SALTIRE and SEAS? An extensive review from bench to bedside. Curr Probl Cardiol 2010;35:284-306.
6. Hutcheson JD, Aikawa E, Merryman WD. Potential drug targets for calcific aortic valve disease. Nat Rev Cardiol 2014;4:218-31.
7. Rajamannan NM, Subramaniam M, Springett M, Sebo TC, Niekrasz M, McConnell JP, et al. Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation 2002;105:2660-5.
8. Drolet MC, Couet J, Arsenault M. Development of aortic valve sclerosis or stenosis in rabbits: role of cholesterol and calcium. J Heart Valve Dis 2008;17:381-7.
9. Drolet MC, Roussel E, Deshaies Y, Couet J, Arsenault M. A high fat/high carbohydrate diet induces aortic valve disease in C57BL/6Jmice. J Am Coll Cardiol 2006;47:850-5.
10. Awan Z, Denis M, Bailey D, Giaid A, Prat A, Goltzman D, et al. The LDLR deficient mouse as a model for aortic calcification and quantification by micro-computed tomography. Atherosclerosis 2011;219:455-62.
11. Garg V, Muth AN, Ransom JF, Schluterman MK, Barnes R, King IN, et al. Mutations in NOTCH1 cause aortic valve disease. Nature 2005;437:270-4.
12. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 1992;71:343-53.
13. Sider KL, Blaser MC, Simmons CA. Animal models of calcific aortic valve disease. Int J Inflamm 2011:364310.
14. Li C, Xu S, Gotlieb AI. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Cardiovasc Pathol 2013;22:1-8.
15. Chester AH, Taylor PM. Molecular and functional characteristics of heart-valve interstitial cells. Philos Trans R Soc Lond B Biol Sci 2007;362:1437-43.
16. Ku CH, Johnson PH, Batten P, Sarathchandra P, Chambers RC, Taylor PM, et al. Collagen synthesis by mesenchymal stem cells and aortic valve interstitial cells in response to mechanical stretch. Cardiovasc Res 2006;71:548-56.
17. Cloyd KL, El-Hamamsy I, Boonrungsiman S, Hedegaard M, Gentleman E, Sarathchandra P, et al. Characterization of porcine aortic valvular interstitial cell 'calcified' nodules. PLoS One 2012;7:e48154.
18. Jian B, Narula N, Li QY, Mohler ER, Levy RJ. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. Ann Thorac Surg 2003;75:457-65 [discussion 65-6].
19. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, et al. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107:2181-4.
20. Guerraty M, Mohler ER. Models of aortic valve calcification. J Investig Med 2007;55:278-83.
21. Mohler ER, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103:1522-8.
22. Monzack EL, Masters KS. Can valvular interstitial cells become true osteoblasts? A side-by-side comparison. J Heart Valve Dis 2011;20:449-63.
23. Arjunon S, Rathan S, Jo H, Yoganathan AP. Aortic valve: mechanical environment and mechanobiology. Ann Biomed Eng 2013;41:1331-46.
24. Deck JD. Endothelial cell orientation on aortic valve leaflets. Cardiovasc Res 1986;20:760-7.
25. Manduteanu I, Popov D, Radu A, Simionescu M. Calf Cardiac Valvular Endothelial-Cells in Culture - Production of Glycosaminoglycans, Prostacyclin and Fibronectin. J Mol Cell Cardiol 1988;20:103-18.
26. Nathan C. Nitric-Oxide as a Secretory Product of Mammalian-Cells. FASEB J 1992;6:3051-64.
27. Gossl M, Khosla S, Zhang X, Higano N, Jordan KL, Loeffler D, et al. Role of Circulating Osteogenic Progenitor Cells in Calcific Aortic Stenosis. J Am Coll Cardiol 2012;60:1945-53.
28. Egan KP, Kim JH, Mohler ER, Pignolo RJ. Role for Circulating Osteogenic Precursor Cells in Aortic Valvular Disease. Arterioscler Thromb Vasc 2011;31:2965-71.
29. Freeman RV, Otto CM. Spectrum of calcific aortic valve disease - Pathogenesis, disease progression, and treatment strategies. Circulation 2005;111:3316-26.
30. Cote N, Mahmut A, Bosse Y, Couture C, Page S, Trahan S, et al. Inflammation Is Associated with the Remodeling of Calcific Aortic Valve Disease. Inflammation 2013;36:573-81.
31. Kaden JJ, Demp fle CE, Grobholz R, Fischer CS, Vocke DC, Kilic R, et al. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. Cardiovasc Pathol 2005;14:80-7.
32. New SEP, Aikawa E. Molecular Imaging Insights Into Early Inflammatory Stages of Arterial and Aortic Valve Calcification. Circ Res 2011;108:1381-91.
33. Wallby L, Steffensen T, Jonasson L, Broqvist M. Inflammatory Characteristics of Stenotic Aortic Valves: A Comparison between Rheumatic and Nonrheumatic Aortic Stenosis. Cardiol Res Pract 2013:895215.
34. Liu AC, Joag VR, Gotlieb AI. The emerging role of valve interstitial cell phenotypes in regulating heart valve pathobiology. Am J Pathol 2007;171:1407-18.
35. Paruchuri S, Yang JH, Aikawa E, Melero-Martin JM, Khan ZA, Loukogeorgakis S, et al. Human pulmonary valve progenitor cells exhibit endothelial/mesenchymal plasticity in response to vascular endothelial growth factor-A and transforming growth factor-beta2. Circ Res 2006;99:861-9.
36. Balachandran K, Alford PW, Wylie-Sears J, Goss JA, Grosberg A, Bischoff J, et al. Cyclic strain induces dual-mode endothelial-mesenchymal transformation of the cardiac valve. Proc Natl Acad Sci U S A 2011;108:19943-8.
37. Sewell-Loftin MK, DeLaughter DM, Peacock JR, Brown CB, Baldwin HS, Barnett JV, et al. Myocardial contraction and hyaluronic acidmechanotransduction in epithelial-to-mesenchymal transformation of endocardial cells. Biomaterials 2014;35:2809-15.
38. Mohler ER, Chawla MK, Chang AW, Vyavahare N, Levy RJ, Graham L, et al. Identification and characterization of calcifying valve cells from human and canine aortic valves. J Heart Valve Dis 1999;8:254-60.
39. Kaden JJ, Bickelhaupt S, Grobholz R, Vahl CF, Hagl S, Brueckmann M, et al. Expression of bone sialoprotein and bone morphogenetic protein-2 in calcific aortic stenosis. J Heart Valve Dis 2004;13:560-6.
40. Cheng SL, Shao JS, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes osteogenesis and suppresses adipogenic differentiation of multipotent mesenchymal progenitors. J Biol Chem 2003;278:45969-77.
41. Yang XP, Meng XZ, Su X, Mauchley DC, Ao LH, Cleveland JC, et al. Bone morphogenic protein 2 induces Runx2 and osteopontin expression in human aortic valve interstitial cells: Role of Smad1 and extracellular signal-regulated kinase 1/2. J Thorac Cardiovasc Surg 2009;138:1008-15.
42. Butcher JT, Nerem RM. Valvular endothelial cells regulate the phenotype of interstitial cells in co-culture: effects of steady shear stress. Tissue Eng 2006;12:905-15.
43. Richards J, El-Hamamsy I, Chen S, Sarang Z, Sarathchandra P, Yacoub MH, et al. Sidespecific endothelial-dependent regulation of aortic valve calcification: interplay of hemodynamics and nitric oxide signaling. Am J Pathol 2013;182:1922-31.
44. Tseng H, Balaoing LR, Grigoryan B, Raphael RM, Killian TC, Souza GR, et al. A three-dimensional co-culture model of the aortic valve using magnetic levitation. Acta Biomater 2014;10:173-82.
45. Chang MY, Potter-Perigo S, Tsoi C, Chait A, Wight TN. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem 2000;275:4766-73.
46. Swindle MM, Makin A, Herron AJ, Clubb FJ, Frazier KS. Swine as models in biomedical research and toxicology testing. Vet Pathol 2012;49:344-56.
47. de Smet BJ, van der Zande J, van der Helm YJ, Kuntz RE, Borst C, Post MJ. The atherosclerotic Yucatan animal model to study the arterial response after balloon angioplasty: the natural history of remodeling. Cardiovasc Res 1998;39:224-32.
48. Simmons CA, Grant GR, Manduchi E, Davies PF. Spatial heterogeneity of endothelial phenotypes correlates with side-specific vulnerability to calcification in normal porcine aortic valves. Circ Res 2005;96:792-9.
49. Johnson CM, Hanson MN, Helgeson SC. Porcine cardiac valvular subendothelial cells in culture: cell isolation and growth characteristics. J Mol Cell Cardiol 1987;19:1185-93.
50. Mulholland DL, Gotlieb AI. Cell biology of valvular interstitial cells. Can J Cardiol 1996;12:231-6.
51. Wang L, Wilshaw SP, Korossis S, Fisher J, Jin Z, Ingham E. Factors influencing the oxygen consumption rate of aortic valve interstitial cells: application to tissue engineering. Tissue Eng Part C Methods 2009;15:355-63.
52. Cushing MC, Liao JT, Anseth KS. Activation of valvular interstitial cells is mediated by transforming growth factor-beta 1 interactions with matrix molecules. Matrix Biol 2005;24:428-37.
53. Pho M, Lee W, Watt DR, Laschinger C, Simmons CA, McCulloch CA. Cofilin is a marker of myofibroblast differentiation in cells from porcine aortic cardiac valves. Am J Physiol Heart Circ Physiol 2008;294:H1767-78.
54. Clark-Greuel JN, Connolly JM, Sorichillo E, Narula NR, Rapoport HS, Mohler ER, et al. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events. Ann Thorac Surg 2007;83:946-53.
55. Kim KM, Chang SH, Trump BF, Spurgeon H. Calcification in aging canine aortic valve. Scan Electron Microsc 1986:1151-6.
56. Aupperle H, Disatian S. Pathology, protein expression and signaling in myxomatous mitral valve degeneration: comparison of dogs and humans. J Vet Cardiol 2012;14:59-71.
57. Hsu HH, Tawfik O, Sun F. Mechanism of dystrophic calcification in rabbit aortas: temporal and spatial distributions of calcifying vesicles and calcification-related structural proteins. Cardiovasc Pathol 2004;13:3-10.
58. Rajamannan NM, Sangiorgi G, Springett M, Arnold K, Mohacsi T, Spagnoli LG, et al. Experimental hypercholesterolemia induces apoptosis in the aortic valve. J Heart Valve Dis 2001;10:371-4.
59. Hsu HH, Camacho NC, Tawfik O, Sun F. Induction of calcification in rabbit aortas by high cholesterol diets: roles of calcifiable vesicles in dystrophic calcification. Atherosclerosis 2002;161:85-94.
60. Swiatek PJ, Lindsell CE, del Amo FF, Weinmaster G, Gridley T. Notch1 is essential for postimplantation development in mice. Genes Dev 1994;8:707-19.
61. Nus M, MacGrogan D, Martinez-Poveda B, Benito Y, Casanova JC, Fernandez-Aviles F, et al. Diet-induced aortic valve disease in mice haploinsufficient for the Notch pathway effector RBPJK/CSL. Arterioscler Thromb Vasc Biol 2011;31:1580-8.
62. Hjortnaes J, Butcher J, Figueiredo JL, Riccio M, Kohler RH, Kozloff KM, et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 2010;31:1975-84.
63. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-40.
64. Sanan DA, Newland DL, Tao R, Marcovina S, Wang J, Mooser V, et al. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: no accentuation by apolipoprotein(a). Proc Natl Acad Sci U S A 1998;95:4544-9.
65. Treuting PM, Dintzis SM. Comparative Anatomy and Histology: A Mouse and Human Atlas. 1st ed. Elsevier; 2011.
66. Aikawa E, Whittaker P, Farber M, Mendelson K, Padera RF, Aikawa M, et al. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006;113:1344-52.
67. Chen JH, Simmons CA. Cell-matrix interactions in the pathobiology of calcific aortic valve disease: critical roles for matricellular, matricrine, and matrix mechanics cues. Circ Res 2011;108:1510-24.
68. Yip CY, Chen JH, Zhao R, Simmons CA. Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol 2009;29:936-42.
69. Gu X, Masters KS. Regulation of valvular interstitial cell calcification by adhesive peptide sequences. J Biomed Mater Res A 2010;93:1620-30.
70. Benton JA, Kern HB, Anseth KS. Substrate properties influence calcification in valvular interstitial cell culture. J Heart Valve Dis 2008;17:689-99.
71. Kunz-Schughart LA, Wenninger S, Neumeier T, Seidl P, Knuechel R. Three-dimensional tissue structure affects sensitivity of fibroblasts to TGF-beta 1. Am J Physiol Cell Physiol 2003;284:C209-19.
72. Butcher JT, Nerem RM. Porcine aortic valve interstitial cells in three-dimensional culture: Comparison of phenotype with aortic smooth muscle cells. J Heart Valve Dis 2004;13:478-85.
73. Vesely I, Noseworthy R. Micromechanics of the fibrosa and the ventricularis in aortic valve leaflets. J Biomech 1992;25:101-13.
74. Sewell-Loftin MK, Brown CB, Baldwin HS, Merryman WD. A novel technique for quantifying mouse heart valve leaflet stiffness with atomic force microscopy. J Heart Valve Dis 2012;21:513-20.
75. Merryman WD, Huang HY, Schoen FJ, Sacks MS. The effects of cellular contraction on aortic valve leaflet flexural stiffness. J Biomech 2006;39:88-96.
76. Haskett D, Johnson G, Zhou A, Utzinger U, Vande Geest J. Microstructural and biomechanical alterations of the human aorta as a function of age and location. Biomech Model Mechanobiol 2010;9:725-36.
77. Merryman WD. Mechano-potential etiologies of aortic valve disease. J Biomech 2010;43:87-92.
78. Akat K, Borggrefe M, Kaden JJ. Aortic valve calcification: basic science to clinical practice. Heart 2009;95:616-23.
79. Cooke JP. Flow, NO, and atherogenesis. Proc Natl Acad Sci U S A 2003;100:768-70.
80. Ng CP, Hinz B, Swartz MA. Interstitial fluid flow induces myofibroblast differentiation and collagen alignment in vitro. J Cell Sci 2005;118:4731-9.
81. Fisher CI, Chen J, Merryman WD. Calcific nodule morphogenesis by heart valve interstitial cells is strain dependent. Biomech Model Mechanobiol 2013;12:5-17.
82. Balachandran K, Sucosky P, Jo H, Yoganathan AP. Elevated cyclic stretch induces aortic valve calcification in a bone morphogenic protein-dependent manner. Am J Pathol 2010;177:49-57.
83. Simmons CA, Nikolovski J, Thornton AJ, Matlis S, Mooney DJ. Mechanical stimulation and mitogen-activated protein kinase signaling independently regulate osteogenic differentiation and mineralization by calcifying vascular cells. J Biomech 2004;37:1531-41.
84. Merryman WD, Lukoff HD, Long RA, Engelmayr GC, Hopkins RA, Sacks MS. Synergistic effects of cyclic tension and transforming growth factor-beta1 on the aortic valve myofibroblast. Cardiovasc Pathol 2007;16:268-76.
85. Walker GA, Masters KS, Shah DN, Anseth KS, Leinwand LA. Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res 2004;95:253-60.
86. Hutcheson JD, Ryzhova LM, Setola V, Merryman WD. 5-HT(2B) antagonism arrests non-canonical TGF-beta1-induced valvular myofibroblast differentiation. J Mol Cell Cardiol 2012;53:707-14.
87. Wipff PJ, Rifkin DB, Meister JJ, Hinz B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 2007;179:1311-23.
88. Cushing MC, Mariner PD, Liao JT, Sims EA, Anseth KS. Fibroblast growth factor represses Smad-mediated myofibroblast activation in aortic valvular interstitial cells. FASEB J 2008;22:1769-77.
89. Hutcheson JD, Chen J, Sewell-Loftin MK, Ryzhova LM, Fisher CI, Su YR, et al. Cadherin-11 regulates cell-cell tension necessary for calcific nodule formation by valvular myofibroblasts. Arterioscler Thromb Vasc Biol 2013;33:114-20.
90. Towler DA. Molecular and cellular aspects of calcific aortic valve disease. Circ Res 2013;113:198-208.
91. Peacock JD, Levay AK, Gillaspie DB, Tao G, Lincoln J. Reduced sox9 function promotes heart valve calcification phenotypes in vivo. Circ Res 2010;106:712-9.
92. Shao JS, Cheng SL, Pingsterhaus JM, Charlton-Kachigian N, Loewy AP, Towler DA. Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals. J Clin Invest 2005;115:1210-20.
93. Yip CY, Blaser MC, Mirzaei Z, Zhong X, Simmons CA. Inhibition of pathological differentiation of valvular interstitial cells by C-type natriuretic peptide. Arterioscler Thromb Vasc Biol 2011;31:1881-9.
94. Rajamannan NM, Subramaniam M, Caira F, Stock SR, Spelsberg TC. Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. Circulation 2005;112:I229-34.
95. Branchetti E, Sainger R, Poggio P, Grau JB, Patterson-Fortin J, Bavaria JE, et al. Antioxidant enzymes reduce DNA damage and early activation of valvular interstitial cells in aortic valve sclerosis. Arterioscler Thromb Vasc Biol 2013;33:e66-74.
96. Miller JD, Chu Y, Brooks RM, Richenbacher WE, Pena-Silva R, Heistad DD. Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J Am Coll Cardiol 2008;52:843-50.
97. Ann EJ, Kim HY, Choi YH, Kim MY, Mo JS, Jung J, et al. Inhibition of Notch1 signaling by Runx2 during osteoblast differentiation. J Bone Miner Res 2011;26:317-30.
98. Acharya A, Hans CP, Koenig SN, Nichols HA, Galindo CL, Garner HR, et al. Inhibitory role of Notch1 in calcific aortic valve disease. PLoS One 2011;6:e27743.
99. Liberman M, Bassi E, Martinatti MK, Lario FC, Wosniak J, Pomerantzeff PM, et al. Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler Thromb Vasc Biol 2008;28:463-70.
100. Langenbach F, Handschel J. Effects of dexamethasone, ascorbic acid and beta-glycerophosphate on the osteogenic differentiation of stem cells in vitro. Stem Cell Res Ther 2013;4:117.
101. Gronowicz G, Woodiel FN, McCarthy MB, Raisz LG. In vitro mineralization of fetal rat parietal bones in defined serum-free medium: effect of beta-glycerol phosphate. J Bone Miner Res 1989;4:313-24.
102. Yu Z, Seya K, Daitoku K, Motomura S, Fukuda I, Furukawa K. Tumor necrosis factor-alpha accelerates the calcification of human aortic valve interstitial cells obtained from patients with calcific aortic valve stenosis via the BMP2-Dlx5 pathway. J Pharmacol Exp Ther 2011;337:16-23.
103. Al-Aly Z, Shao JS, Lai CF, Huang E, Cai J, Behrmann A, et al. Aortic Msx2-Wnt calcification cascade is regulated by TNF-alpha-dependent signals in diabetic Ldlr-/-mice. Arterioscler Thromb Vasc Biol 2007;27:2589-96.
104. Rusanescu G, Weissleder R, Aikawa E. Notch signaling in cardiovascular disease and calcification. Curr Cardiol Rev 2008;4:148-56.
105. Zeng Q, Jin C, Ao L, Cleveland JC, Song R, Xu D, et al. Cross-talk between the Toll-like receptor 4 and Notch1 pathways augments the inflammatory response in the interstitial cells of stenotic human aortic valves. Circulation 2012;126:S222-30.
106. Yang X, Fullerton DA, Su X, Ao L, Cleveland JC, Meng X. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol 2009;53:491-500.
107. O'Brien KD. Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 2006;26:1721-8.
108. Kaden JJ, Bickelhaupt S, Grobholz R, Haase KK, Sarikoc A, Kilic R, et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulate aortic valve calcification. J Mol Cell Cardiol 2004;36:57-66.
109. Kawaguchi H, Akune T, Yamaguchi M, Ohba S, Ogata N, Chung UI, et al. Distinct effects of PPARgamma insufficiency on bone marrow cells, osteoblasts, and osteoclastic cells. J Bone Miner Metab 2005;23:275-9.
110. Kennedy JA, Hua X, Mishra K, Murphy GA, Rosenkranz AC, Horowitz JD. Inhibition of calcifying nodule formation in cultured porcine aortic valve cells by nitric oxide donors. Eur J Pharmacol 2009;602:28-35.
111. Rajamannan NM, Subramaniam M, Stock SR, Stone NJ, Springett M, Ignatiev KI, et al. Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. Heart 2005;91:806-10.
112. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM, et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008;283:15319-27.
113. Galeone A, Brunetti G, Oranger A, Greco G, Di Benedetto A, Mori G, et al. Aortic valvular interstitial cells apoptosis and calcification are mediated by TNF-related apoptosis-inducing ligand. Int J Cardiol 2013;169:296-304.
114. Benton JA, Kern HB, Leinwand LA, Mariner PD, Anseth KS. Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol 2009;29:1950-7.
115. Cai ZJ, Li F, Gong W, Liu WJ, Duan QL, Chen C, et al. Endoplasmic Reticulum Stress Participates in Aortic Valve Calcification in Hypercholesterolemic Animals. Arterioscler Thromb Vasc 2013;33:2345-54.
116. Caira FC, Stock SR, Gleason TG, McGee EC, Huang J, Bonow RO, et al. Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation. J Am Coll Cardiol 2006;47:1707-12.
117. Connolly JM, Alferiev I, Clark-Gruel JN, Eidelman N, Sacks M, Palmatory E, et al. Triglycidylamine crosslinking of porcine aortic valve cusps or bovine pericardium results in improved biocompatibility, biomechanics, and calcification resistance: chemical and biological mechanisms. Am J Pathol 2005;166:1-13.
118. Bertazzo S, Gentleman E, Cloyd KL, Chester AH, Yacoub MH, Stevens MM. Nanoanalytical electron microscopy reveals fundamental insights into human cardiovascular tissue calcification. Nat Mater 2013;12:576-83.
119. Otero EU, Sathaiah S, Silveira L, Pomerantzeff PMA, Pasqualucci CAG. Raman spectroscopy for diagnosis of calcification in human heart valves. Spectrosc Int J 2004;18:75-84.
120. Tzang O, Kfir K, Flaxer E, Cheshnovsky O, Einav S. Detection of microcalcification in tissue with Raman spectroscopy. Cardiovasc Eng Technol 2011;2:228-33.
121. Latif N, Sarathchandra P, Chester AH, Yacoub MH. Expression of smooth muscle cell markers and co-activators in calcified aortic valves. Eur Heart J 2014.
122. Brockbank KG, Song YC. Mechanisms of bioprosthetic heart valve calcification. Transplantation 2003;75:1133-5.
123. Atomic absorption spectroscopy. Accessed 07, 2014, at http://www.kau.edu.sa/Files/130002/Files/6785-AAs.pdf.
124. Gregory CA, Gunn WG, Peister A, Prockop DJ. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 2004;329:77-84.
125. von Kossa's Method - Calcium. Accessed 07, 2014, at http://library.med.utah.edu/WebPath/HISTHTML/MANUALS/VONKOSSA.PDF.
126. Bonewald LF, Harris SE, Rosser J, Dallas MR, Dallas SL, Camacho NP, et al. von Kossa staining alone is not sufficient to confirm that mineralization in vitro represents bone formation. Calcif Tissue Int 2003;72:537-47.
127. Rungby J, Kassem M, Eriksen EF, Danscher G. The von Kossa reaction for calcium deposits: silver lactate staining increases sensitivity and reduces background. Histochem J 1993;25:446-51.
128. Calcium Reagent Arsenazo III; 2010 [Accessed 07, 2014, at].
129. Janssen JW, Helbing AR. Arsenazo III: an improvement of the routine calcium determination in serum. Eur J Clin Chem Clin Biochem 1991;29:197-201.
130. Calcium oCPC. Accessed 07, 2014, at https://www.beckmancoulter.com/wsrportal/techdocs?docname=/cis/BAOSR6x13/%25%25/EN-CALCIUM%20(oCPC).pdf; 2009.
131. Delogne C, Lawford PV, Habesch SM, Carolan VA. Characterization of the calcification of cardiac valve bioprostheses by environmental scanning electron microscopy and vibrational spectroscopy. J Microsc 2007;228:62-77.
132. Erni R, Rossell MD, Kisielowski C, Dahmen U. Atomic-resolution imaging with a sub-50-pm electron probe. Phys Rev Lett 2009;102:096101.
133. Energy Dispersive Spectroscopy on the SEM: A Primer. Accessed 07, 2014, at http://www.charfac.umn.edu/instruments/eds-on-sem-primer.pdf.
134. Alkaline Phosphatase Assay Kit (Colorimetric) ab83369. Accessed 07, 2014, at http://www.abcam.com/alkaline-phosphatase-assay-kit-colorimetric-ab83369.html.
135. Kaden JJ, Dempfle CE, Kilic R, Sarikoc A, Hagl S, Lang S, et al. Influence of receptor activator of nuclear factor kappa B on human aortic valve myofibroblasts. Exp Mol Pathol 2005;78:36-40.
136. Grases F, Sohnel O, Zelenkova M. Ultrafine structure of human aortic valve calcific deposits. J Cytol Histol 2014;5:214.
137. Jastrzebska M, Mroz I, Barwinski B, Zalewska-Rejdak J, Turek A, Cwalina B. Supramolecular structure of human aortic valve and pericardial xenograft material: atomic force microscopy study. J Mater Sci Mater Med 2008;19:249-56.
138. Lommi JI, Kovanen PT, Jauhiainen M, Lee-Rueckert M, Kupari M, Helske S. High-density lipoproteins (HDL) are present in stenotic aortic valves and may interfere with the mechanisms of valvular calcification. Atherosclerosis 2011;219:538-44.
139. Merryman WD, Bieniek PD, Guilak F, Sacks MS. Viscoelastic properties of the aortic valve interstitial cell. J Biomech Eng 2009;131:041005.
140. Merryman WD, Youn I, Lukoff HD, Krueger PM, Guilak F, Hopkins RA, et al. Correlation between heart valve interstitial cell stiffness and transvalvular pressure: implications for collagen biosynthesis. Am J Physiol Heart Circ Physiol 2006;290:H224-31.